Trn Pharma Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 21-06-2024
- Paid Up Capital ₹ 6.18 M
as on 21-06-2024
- Company Age 33 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 8.00 Cr
as on 21-06-2024
- Revenue %
(FY 2021)
- Profit -64.80%
(FY 2021)
- Ebitda -181.80%
(FY 2021)
- Net Worth -2.85%
(FY 2021)
- Total Assets -0.96%
(FY 2021)
About Trn Pharma
The Corporate was formerly known as Menon Pharma Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 6.18 M.
The company has closed loans amounting to ₹8.00 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Kannan Anantharam and Raghunandan Thottappillil serve as directors at the Company.
- CIN/LLPIN
U24239MH1991PTC061319
- Company No.
061319
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Apr 1991
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Trn Pharma?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kannan Anantharam  | Director | 02-Nov-2009 | Current |
| Raghunandan Thottappillil | Director | 23-Apr-1991 | Current |
Financial Performance of Trn Pharma.
Trn Pharma Private Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 64.8% decrease in profit. The company's net worth dipped by a decrease of 2.85%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Trn Pharma?
In 2021, Trn Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Menon Impex Private LimitedActive 41 years 1 monthKannan Anantharam and Raghunandan Thottappillil are mutual person
- Anjali Technology Holdings Private LimitedActive 24 years 6 months
Kannan Anantharam is a mutual person
- Ambernath Organics Private LimitedActive 39 years 4 months
Raghunandan Thottappillil is a mutual person
- Eloilex Laboratories Private LimitedActive 36 years 8 months
Raghunandan Thottappillil is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Indian Bank Creation Date: 09 Jun 1992 | ₹2.00 Cr | Satisfied |
Indian Bank Creation Date: 09 Jun 1992 | ₹6.00 Cr | Satisfied |
How Many Employees Work at Trn Pharma?
Unlock and access historical data on people associated with Trn Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Trn Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Trn Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
